Home›Search›Neurodegenerative Diseases

Neurodegenerative Diseases

S. Karger AG · Switzerland · Est. 1989

ISSN1660-2862

SJR Q2✓ WOS SCIE✓ Scopus / SJR

/ 100

Medium Risk

Score Breakdown

✓ WoS SCIE/SSCI+25

✓ Scopus Q2+18

Total53

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

0.852

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

0.659

Total Works

1,282

Total Citations

40,539

2yr Mean Citedness

1.13

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

This journal focuses on neurodegenerative diseases, examining their underlying pathophysiological mechanisms, clinical manifestations, and diagnostic approaches. It covers conditions such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and dementia with Lewy bodies, exploring motor and non-motor symptoms, cognitive decline, and the role of factors like protein misfolding, neuroinflammation, and genetic predispositions. The journal also investigates therapeutic strategies, including pharmacological, non-pharmacological, and emerging treatments, as well as the use of advanced imaging techniques and speech analysis for diagnosis and monitoring disease progression. The blood-brain barrier's role in neurodegeneration and its assessment via MRI are also key areas of interest.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Top 50% in field

General Information

Country / RegionSwitzerland

Primary LanguageEnglish

1st Year Published1989

Annual Volume~ 29 articles / year

StatusActive (last: 2026)

Total Publications1,282

Publisher OrgKarger Publishers

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

S. Karger AG

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1660-2862

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

NeurologyQ2

Neurology (clinical)Q2

Subject Classification

Web of Science Categories

Clinical NeurologyNeurosciences

Scopus Categories

Neurology (clinical)Neurology

Research Topics (OpenAlex)

Alzheimer's disease research and treatmentsParkinson's Disease Mechanisms and TreatmentsAmyotrophic Lateral Sclerosis ResearchDementia and Cognitive Impairment ResearchDiverse Scientific and Economic StudiesGenetic Neurodegenerative DiseasesHuman auditory perception and evaluationNeurological disorders and treatmentsCholinesterase and Neurodegenerative DiseasesNeuroscience and Neuropharmacology Research